Bateman Lab (IMAGE)
Caption
WashU Medicine’s Randall Bateman, MD, (right) is a co-founder of C2N Diagnostics, a WashU startup that received FDA clearance for its PrecivityAD2 test to aid in Alzheimer’s evaluation.
Credit
Matt Miller/WashU Medicine
Usage Restrictions
This image is to be used in accordance with the mission, policies and guidelines of WashU Medicine. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information.
License
Original content